PillCamColon2 after incomplete colonoscopy - A prospective multicenter study

Table 2 Demographics, reasons for termination of optical colonoscopy, and results of colon capsule endoscopy for protocol A and B n (%)

	Protocol A (CCE next day)	Protocol B ( CCE within 30 d)	Significance
Demographics
Patients	38 (51.4)	36 (48.6)
Female	20/38 (52.6)	24/36 (66.7)
Age, mean ± SD	68.0 ± 12.8 yr	63.9 ± 13.0 yr
Body mass index	26.0 ± 3.9	26.5 ± 4.9
Reasons for termination of colonoscopy
Looping of colon	23/38 (60.5)	23/36 (63.9)
Angulation of colon	6/38 (15.8)	5/36 (13.9)
Susp. adhesions	5/38 (13.2)	6/36 (16.7)
Risk of perforation	2/38 (5.3)	0	P = 0.710 (NS); χ2 test
Sedation problems	2/38 (5.3)	2/36 (5.6)
Results of CCE
Complete CCE	24/38 (63.3)	24/36 (66.7)	P = 0.560 (NS); χ2 test
Complementation of colonoscopy	34/38 (89.5)	35/36 (97.2)	P = 0.350 (NS); χ2 test
Adequate cleansing	25/36 (69.4)	23/36 (63.9)	P = 0.820 (NS); χ2 test
Patients with significant colon polyps	10/38 (26.3)	11/36 (30.6)	P = 0.500 (NS); χ2 test
Patients with other colon findings	0	Angiectasia (n = 3)	P = 0.045; χ2 test
		Diverticulitis (n = 1)
Patients with small bowel findings	Angiectasia (n = 1)	0	P = 0.174 (NS); χ2 test
	Crohn’s disease (n = 1)
Patients with upper GI findings	Reflux esophagitis (n = 1)	Reflux-esophagitis (n = 1)	P = 0.949 (NS); χ2 test
	Upper GI-bleeding (n = 1)	Susp. Barrett esophagus (n = 1)
	Gastric polyps (n = 1)	Gastric erosions (n = 1)

CCE: Colon capsule endoscopy.